481 related articles for article (PubMed ID: 26247726)
1. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
[TBL] [Abstract][Full Text] [Related]
2. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma.
Shang X; Vasudevan SA; Yu Y; Ge N; Ludwig AD; Wesson CL; Wang K; Burlingame SM; Zhao YJ; Rao PH; Lu X; Russell HV; Okcu MF; Hicks MJ; Shohet JM; Donehower LA; Nuchtern JG; Yang J
Oncogene; 2010 Sep; 29(35):4938-46. PubMed ID: 20562916
[TBL] [Abstract][Full Text] [Related]
3. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26).
Song M; Park JE; Park SG; Lee DH; Choi HK; Park BC; Ryu SE; Kim JH; Cho S
Biochem Biophys Res Commun; 2009 Apr; 381(4):491-5. PubMed ID: 19233143
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of dual-specificity phosphatase 26 by ethyl-3,4-dephostatin: Ethyl-3,4-dephostatin as a multiphosphatase inhibitor.
Seo H; Cho S
Pharmazie; 2016 Apr; 71(4):196-200. PubMed ID: 27209699
[TBL] [Abstract][Full Text] [Related]
5. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
6. DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs.
Patterson KI; Brummer T; Daly RJ; O'Brien PM
Biochim Biophys Acta; 2010 Sep; 1803(9):1003-12. PubMed ID: 20347885
[TBL] [Abstract][Full Text] [Related]
7. A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity.
Yu W; Imoto I; Inoue J; Onda M; Emi M; Inazawa J
Oncogene; 2007 Feb; 26(8):1178-87. PubMed ID: 16924234
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
[TBL] [Abstract][Full Text] [Related]
9. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Xu L; Chen S; Bergan RC
Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
[TBL] [Abstract][Full Text] [Related]
10. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways.
Cheng J; Fan YH; Xu X; Zhang H; Dou J; Tang Y; Zhong X; Rojas Y; Yu Y; Zhao Y; Vasudevan SA; Zhang H; Nuchtern JG; Kim ES; Chen X; Lu F; Yang J
Cell Death Dis; 2014 Feb; 5(2):e1079. PubMed ID: 24556694
[TBL] [Abstract][Full Text] [Related]
11. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways.
Ke JY; Zhang W; Gong RS; Cen WJ; Huang HQ; Li YR; Kong WD; Jiang JW
Tumour Biol; 2016 Nov; 37(11):14863-14872. PubMed ID: 27644244
[TBL] [Abstract][Full Text] [Related]
12. Atomic structure of dual-specificity phosphatase 26, a novel p53 phosphatase.
Lokareddy RK; Bhardwaj A; Cingolani G
Biochemistry; 2013 Feb; 52(5):938-48. PubMed ID: 23298255
[TBL] [Abstract][Full Text] [Related]
13. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
[TBL] [Abstract][Full Text] [Related]
14. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK.
Bu HQ; Liu DL; Wei WT; Chen L; Huang H; Li Y; Cui JH
Oncol Rep; 2014 Feb; 31(2):975-82. PubMed ID: 24297112
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion.
Tanuma N; Nomura M; Ikeda M; Kasugai I; Tsubaki Y; Takagaki K; Kawamura T; Yamashita Y; Sato I; Sato M; Katakura R; Kikuchi K; Shima H
Oncogene; 2009 Feb; 28(5):752-61. PubMed ID: 19043453
[TBL] [Abstract][Full Text] [Related]
16. The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11'-dideoxyverticillin-induced G2/M arrest.
Chen Y; Miao ZH; Zhao WM; Ding J
FEBS Lett; 2005 Jul; 579(17):3683-90. PubMed ID: 15963507
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking.
Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y
Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
[TBL] [Abstract][Full Text] [Related]
19. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
20. p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment.
Marengo B; De Ciucis CG; Ricciarelli R; Furfaro AL; Colla R; Canepa E; Traverso N; Marinari UM; Pronzato MA; Domenicotti C
Cell Death Dis; 2013 Apr; 4(4):e589. PubMed ID: 23579276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]